Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease

BACKGROUND: Deterioration of cognitive functioning is a debilitating symptom in many neurodegenerative diseases, such as Huntington's disease (HD). To date, there are no effective treatments for the cognitive problems associated with HD. Cognitive assessment outcomes will have a central role in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Stout, Julie C, Jones, Rebecca, Labuschagne, Izelle, O'Regan, Alison M, Say, Miranda J, Dumas, Eve M, Queller, Sarah, Justo, Damian, Santos, Rachelle Dar, Coleman, Allison, Hart, Ellen P, Dürr, Alexandra, Leavitt, Blair R, Roos, Raymund A, Langbehn, Doug R, Tabrizi, Sarah J, Frost, Chris
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2012
Gaiak:
Cognitive Neurology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368487/
https://ncbi.nlm.nih.gov/pubmed/22566599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2011-301940
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak